Join the club for FREE to access the whole archive and other member benefits.

Giuseppe Mancia

Emeritus Professor of Medicine at University of Milano-Bicocca

Giuseppe Mancia is Emeritus Professor of Medicine at the University of Milano-Bicocca, Director of the Center of Epidemiology and Clinical Trials of the IRCSS Istituto Auxologico Italiano and President of the Hypertension Foundation of the European Society of Hypertension (ESH). His research addresses clinical and basic aspects of hypertension,metabolic abnormalities and cardiovascular diseases. He is past-President of the International Society of Hypertension (ISH), the ESH, the European Society of Clinical Investigation, the Italian Society of Hypertension, the Working Group on Hypertension and the Heart of the European Society of Cardiology (ESC) and the 2003, 2007, 2009 and 2013 ESH/ESC Guidelines Committee on Hypertension. Professor Mancia has received many international and national research awards including the Heymans Award (International Pharmacology Society), Wright Award (Australian High Blood Pressure Council), Volhard and Tigersted Awards (ISH), Folkow Award (ESH), International Recordati Prize and Invernizzi Prize for Medicine. He has received several honorary professorships and degrees Honoris Causa from several Universities, and is Honorary Member of many international Scientific Societies. He has published more than 1500 papers in peer-reviewed Journals and edited or authored more than 20 books on hypertension, cardiovascular and metabolic diseases. He is in the list of the “highly cited” of ISI (Philadelphia). His papers have received more than 81.000 citations with a H-index of 125.

 giuseppe-mancia-4a23727a

See also: Academia University of Milano - Bicocca - University of Milano - Bicocca is located in Bicocca district in Milan

Details last updated 18-Jun-2020

Giuseppe Mancia News

Antihypertensive drugs have survival benefits even in frail elderly

American Heart Association - 08-Jun-2020

But in some countries due to high cost elderly people may not be able to afford these drugs

Read more...